Screener
Every US-listed company's last full fiscal year, from its SEC filings. Find a business worth understanding first; its price comes after.
Gross marginOver 70%Stock payUnder 5%Balance sheetNet cash23 companies
Add filter
Owner earnings
Share count
Coverage
| Company | Revenue | Growth |
|---|---|---|
| ELVELEVANCE HEALTH, INC. | $199.1B | +12.5% |
| MUMicron Technology, Inc. | $133.2B | +256.3% |
| SNDKSandisk Corporation | $20.2B | – |
| TCOMTrip.com Group Limited | $8.9B | +22.2% |
| FTNTFORTINET, INC. | $6.8B | +14.2% |
| EWEDWARDS LIFESCIENCES CORPORATION | $6.1B | +11.5% |
| WBWEIBO CORPORATION | $1.8B | +0.1% |
| ZDZIFF DAVIS, INC. | $1.5B | +3.5% |
| INDVIndivior Pharmaceuticals, Inc. | $1.2B | +4.3% |
| NVAXNOVAVAX, INC | $1.1B | +64.7% |
| BBBlackBerry Limited | $549.1M | +2.7% |
| MDXGMIMEDX GROUP, INC. | $418.6M | +20.0% |
| INVAINNOVIVA, INC. | $411.3M | +14.7% |
| TCMDTactile Systems Technology, Inc. | $329.5M | +12.5% |
| RIGLRIGEL PHARMACEUTICALS, INC. | $294.3M | +64.1% |
| AMPYAMPLIFY ENERGY CORP. | $263.4M | -10.6% |
| BODIThe Beachbody Company, Inc. | $251.7M | -39.9% |
| NCMINATIONAL CINEMEDIA, INC. | $243.2M | +1.0% |
| AKBAAKEBIA THERAPEUTICS, INC. | $236.2M | +47.5% |
| PBYIPUMA BIOTECHNOLOGY, INC. | $228.4M | -0.9% |
| SBCSBC Medical Group Holdings Incorporated | $173.6M | -15.5% |
| MTEXMANNATECH INC | $108.0M | -8.3% |
| CARLCARLSMED, INC. | $50.5M | +85.9% |
From SEC XBRL frames: each company's fiscal year closest to the calendar year, as filed. Float stands in for size: we show no market prices here. Cash-flow margins say little about banks and insurers. Figures refreshed 2026-11-01.